Guangsheng He

21PUBLICATIONS
17CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedHaematologyHaematological tumoursPharmacogenomicsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jun 13, 2026
Efficacy and safety of crovalimab versus eculizumab in complement inhibitor-naïve patients with paroxysmal nocturnal hemoglobinuria: Chinese subgroup analysis of the phase 3 COMMODORE 2 study.

|Apr 13, 2026
Management strategy in aplastic anemia patients with HBV infection following intensive immunosuppressive therapy in Chinese cohort: prophylactic antiviral therapy may not be necessary with close monitoring.

Yawen Zhang, Xiaoyu Chen, Ting Zhang

|Mar 20, 2026
Case report: persistent anemia after eculizumab in paroxysmal nocturnal hemoglobinuria: non-dominantly active intravascular hemolysis.

Baozhi Fang, Xiao Yu, Yifei Zhou

|Dec 12, 2025
Integration of genomic and clinical variables improves the prediction of myelodysplastic syndromes to acute myeloid leukaemia transformation and prognosis.

Huimin Jin, Zhen Guo, Liying Zhu

|Aug 25, 2025
Severe hemolysis flare of refractory autoimmune hemolytic anemia with positive complement component C3d responsive to Iptacopan with cyclophosphamide and prednisone: a case report.

Yawen Zhang, Yuemin Gong, Guangsheng He

|Nov 13, 2024
Safety of Crovalimab Versus Eculizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria (PNH): Pooled Results From the Phase 3 COMMODORE Studies.

Alexander Röth, Rong Fu, Guangsheng He

Pageof 4

Frequent Collaborators

2 joint publications

Alexander Röth

2 joint publications

Yawen Zhang

1 joint publications

Yaqi Shen

1 joint publications

Paola Guglielmelli